Home > > > Report Detail

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Biosimilar Market 2018, Forecast to 2023

Publisher Name :
Date: 07-Jan-2019
No. of pages: 135

A product is termed as biosimilar product, if it is a biological product with similar characteristics as that of a reference biological product, which possesses approval from agencies such as FDA. There would not be any major clinical difference in effectiveness and safety as that of reference product. Biosimilar products are made of complex molecules with high molecular weight produced through genetic engineering in living cells. Biologics drugs are costlier than respective chemical drugs. Biosimilar drugs can save around 30 to 40 % in terms of price relative to the respective biologics drugs. Biosimilars are useful for the treatment of illnesses such as anemia, autoimmune diseases, cancer, diabetes, growth hormone deficiencies, hematological diseases, kidney failure, rheumatoid arthritis and others. For the manufacturing of biosimilars, manufacturers have to develop environments that are ideal for the living cells, which remain sensitive to environmental conditions. Moreover, they need to develop distinctive process to entice the living cells for producing similar outcome to a prevalent biological treatment. The substitution of biological drugs with biosimilar drugs can save lot of money for public health care sector and patients. The regulatory authorities in developed nations are promoting biosimilar products.

Scope of the Report:

This report focuses on the Biosimilar in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Biosimilar is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Allergan plc

- BIOCAD

- Biocon

- BioXpress Therapeutics SA

- Boehringer Ingelheim GmbH

- Celltrion Inc.

- Coherus BioSciences, Inc

- Dr. Reddy's Laboratories Ltd.

- Genor BioPharma Co. Ltd

- Intas Pharmaceuticals Limited

- Novartis AG

- Pfizer, Inc.

- Reliance Life Sciences

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Human Growth Hormones

- Monoclonal Antibodies

- Insulin

- Peptides

- Erythropoietin

- Others

Market Segment by Applications, can be divided into

- Oncology

- Chronic and Autoimmune Diseases

- Growth Hormone Deficiency

- Infectious Diseases

- Others

There are 15 Chapters to deeply display the global Biosimilar market.

Chapter 1, to describe Biosimilar Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Biosimilar, with sales, revenue, and price of Biosimilar, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Biosimilar, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Biosimilar market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Biosimilar sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Biosimilar Market 2018, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Biosimilar Introduction
1.2 Market Analysis by Type
1.2.1 Human Growth Hormones
1.2.2 Monoclonal Antibodies
1.2.3 Insulin
1.2.4 Peptides
1.2.5 Erythropoietin
1.2.6 Others
1.3 Market Analysis by Applications
1.3.1 Oncology
1.3.2 Chronic and Autoimmune Diseases
1.3.3 Growth Hormone Deficiency
1.3.4 Infectious Diseases
1.3.5 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Allergan plc
2.1.1 Business Overview
2.1.1.1 Allergan plc Description
2.1.1.2 Allergan plc Headquarter, Main Business and Finance Overview
2.1.2 Allergan plc Biosimilar Product Introduction
2.1.2.1 Biosimilar Production Bases, Sales Regions and Major Competitors
2.1.2.2 Biosimilar Product Information
2.1.3 Allergan plc Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Allergan plc Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Allergan plc Biosimilar Market Share in 2017
2.2 BIOCAD
2.2.1 Business Overview
2.2.1.1 BIOCAD Description
2.2.1.2 BIOCAD Headquarter, Main Business and Finance Overview
2.2.2 BIOCAD Biosimilar Product Introduction
2.2.2.1 Biosimilar Production Bases, Sales Regions and Major Competitors
2.2.2.2 Biosimilar Product Information
2.2.3 BIOCAD Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 BIOCAD Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global BIOCAD Biosimilar Market Share in 2017
2.3 Biocon
2.3.1 Business Overview
2.3.1.1 Biocon Description
2.3.1.2 Biocon Headquarter, Main Business and Finance Overview
2.3.2 Biocon Biosimilar Product Introduction
2.3.2.1 Biosimilar Production Bases, Sales Regions and Major Competitors
2.3.2.2 Biosimilar Product Information
2.3.3 Biocon Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Biocon Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Biocon Biosimilar Market Share in 2017
2.4 BioXpress Therapeutics SA
2.4.1 Business Overview
2.4.1.1 BioXpress Therapeutics SA Description
2.4.1.2 BioXpress Therapeutics SA Headquarter, Main Business and Finance Overview
2.4.2 BioXpress Therapeutics SA Biosimilar Product Introduction
2.4.2.1 Biosimilar Production Bases, Sales Regions and Major Competitors
2.4.2.2 Biosimilar Product Information
2.4.3 BioXpress Therapeutics SA Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 BioXpress Therapeutics SA Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global BioXpress Therapeutics SA Biosimilar Market Share in 2017
2.5 Boehringer Ingelheim GmbH
2.5.1 Business Overview
2.5.1.1 Boehringer Ingelheim GmbH Description
2.5.1.2 Boehringer Ingelheim GmbH Headquarter, Main Business and Finance Overview
2.5.2 Boehringer Ingelheim GmbH Biosimilar Product Introduction
2.5.2.1 Biosimilar Production Bases, Sales Regions and Major Competitors
2.5.2.2 Biosimilar Product Information
2.5.3 Boehringer Ingelheim GmbH Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Boehringer Ingelheim GmbH Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Boehringer Ingelheim GmbH Biosimilar Market Share in 2017
2.6 Celltrion Inc.
2.6.1 Business Overview
2.6.1.1 Celltrion Inc. Description
2.6.1.2 Celltrion Inc. Headquarter, Main Business and Finance Overview
2.6.2 Celltrion Inc. Biosimilar Product Introduction
2.6.2.1 Biosimilar Production Bases, Sales Regions and Major Competitors
2.6.2.2 Biosimilar Product Information
2.6.3 Celltrion Inc. Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Celltrion Inc. Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Celltrion Inc. Biosimilar Market Share in 2017
2.7 Coherus BioSciences, Inc
2.7.1 Business Overview
2.7.1.1 Coherus BioSciences, Inc Description
2.7.1.2 Coherus BioSciences, Inc Headquarter, Main Business and Finance Overview
2.7.2 Coherus BioSciences, Inc Biosimilar Product Introduction
2.7.2.1 Biosimilar Production Bases, Sales Regions and Major Competitors
2.7.2.2 Biosimilar Product Information
2.7.3 Coherus BioSciences, Inc Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Coherus BioSciences, Inc Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Coherus BioSciences, Inc Biosimilar Market Share in 2017
2.8 Dr. Reddy's Laboratories Ltd.
2.8.1 Business Overview
2.8.1.1 Dr. Reddy's Laboratories Ltd. Description
2.8.1.2 Dr. Reddy's Laboratories Ltd. Headquarter, Main Business and Finance Overview
2.8.2 Dr. Reddy's Laboratories Ltd. Biosimilar Product Introduction
2.8.2.1 Biosimilar Production Bases, Sales Regions and Major Competitors
2.8.2.2 Biosimilar Product Information
2.8.3 Dr. Reddy's Laboratories Ltd. Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Dr. Reddy's Laboratories Ltd. Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Dr. Reddy's Laboratories Ltd. Biosimilar Market Share in 2017
2.9 Genor BioPharma Co. Ltd
2.9.1 Business Overview
2.9.1.1 Genor BioPharma Co. Ltd Description
2.9.1.2 Genor BioPharma Co. Ltd Headquarter, Main Business and Finance Overview
2.9.2 Genor BioPharma Co. Ltd Biosimilar Product Introduction
2.9.2.1 Biosimilar Production Bases, Sales Regions and Major Competitors
2.9.2.2 Biosimilar Product Information
2.9.3 Genor BioPharma Co. Ltd Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Genor BioPharma Co. Ltd Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Genor BioPharma Co. Ltd Biosimilar Market Share in 2017
2.10 Intas Pharmaceuticals Limited
2.10.1 Business Overview
2.10.1.1 Intas Pharmaceuticals Limited Description
2.10.1.2 Intas Pharmaceuticals Limited Headquarter, Main Business and Finance Overview
2.10.2 Intas Pharmaceuticals Limited Biosimilar Product Introduction
2.10.2.1 Biosimilar Production Bases, Sales Regions and Major Competitors
2.10.2.2 Biosimilar Product Information
2.10.3 Intas Pharmaceuticals Limited Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Intas Pharmaceuticals Limited Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Intas Pharmaceuticals Limited Biosimilar Market Share in 2017
2.11 Novartis AG
2.11.1 Business Overview
2.11.2 Novartis AG Biosimilar Product Introduction
2.11.3 Novartis AG Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Pfizer, Inc.
2.12.1 Business Overview
2.12.2 Pfizer, Inc. Biosimilar Product Introduction
2.12.3 Pfizer, Inc. Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Reliance Life Sciences
2.13.1 Business Overview
2.13.2 Reliance Life Sciences Biosimilar Product Introduction
2.13.3 Reliance Life Sciences Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Biosimilar Market Competition, by Manufacturer
3.1 Global Biosimilar Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Biosimilar Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Biosimilar Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Biosimilar Manufacturer Market Share in 2017
3.4.2 Top 5 Biosimilar Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Biosimilar Market Analysis by Regions
4.1 Global Biosimilar Sales, Revenue and Market Share by Regions
4.1.1 Global Biosimilar Sales by Regions (2013-2018)
4.1.2 Global Biosimilar Revenue by Regions (2013-2018)
4.2 North America Biosimilar Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Biosimilar Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Biosimilar Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Biosimilar Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Biosimilar Sales, Revenue and Growth Rate (2013-2018)
5 North America Biosimilar by Countries, Type, Application and Manufacturers
5.1 North America Biosimilar Sales, Revenue and Market Share by Countries
5.1.1 North America Biosimilar Sales by Countries (2013-2018)
5.1.2 North America Biosimilar Revenue by Countries (2013-2018)
5.1.3 United States Biosimilar Sales and Growth Rate (2013-2018)
5.1.4 Canada Biosimilar Sales and Growth Rate (2013-2018)
5.1.5 Mexico Biosimilar Sales and Growth Rate (2013-2018)
5.2 North America Biosimilar Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Biosimilar Sales by Manufacturers (2016-2017)
5.2.2 North America Biosimilar Revenue by Manufacturers (2016-2017)
5.3 North America Biosimilar Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Biosimilar Sales and Sales Share by Type (2013-2018)
5.3.2 North America Biosimilar Revenue and Revenue Share by Type (2013-2018)
5.4 North America Biosimilar Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Biosimilar Sales and Sales Share by Application (2013-2018)
5.4.2 North America Biosimilar Revenue and Revenue Share by Application (2013-2018)
6 Europe Biosimilar by Countries, Type, Application and Manufacturers
6.1 Europe Biosimilar Sales, Revenue and Market Share by Countries
6.1.1 Europe Biosimilar Sales by Countries (2013-2018)
6.1.2 Europe Biosimilar Revenue by Countries (2013-2018)
6.1.3 Germany Biosimilar Sales and Growth Rate (2013-2018)
6.1.4 UK Biosimilar Sales and Growth Rate (2013-2018)
6.1.5 France Biosimilar Sales and Growth Rate (2013-2018)
6.1.6 Russia Biosimilar Sales and Growth Rate (2013-2018)
6.1.7 Italy Biosimilar Sales and Growth Rate (2013-2018)
6.2 Europe Biosimilar Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Biosimilar Sales by Manufacturers (2016-2017)
6.2.2 Europe Biosimilar Revenue by Manufacturers (2016-2017)
6.3 Europe Biosimilar Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Biosimilar Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Biosimilar Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Biosimilar Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Biosimilar Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Biosimilar Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Biosimilar by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Biosimilar Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Biosimilar Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Biosimilar Revenue by Countries (2013-2018)
7.1.3 China Biosimilar Sales and Growth Rate (2013-2018)
7.1.4 Japan Biosimilar Sales and Growth Rate (2013-2018)
7.1.5 Korea Biosimilar Sales and Growth Rate (2013-2018)
7.1.6 India Biosimilar Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Biosimilar Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Biosimilar Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Biosimilar Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Biosimilar Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Biosimilar Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Biosimilar Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Biosimilar Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Biosimilar Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Biosimilar Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Biosimilar Revenue and Revenue Share by Application (2013-2018)
8 South America Biosimilar by Countries, Type, Application and Manufacturers
8.1 South America Biosimilar Sales, Revenue and Market Share by Countries
8.1.1 South America Biosimilar Sales by Countries (2013-2018)
8.1.2 South America Biosimilar Revenue by Countries (2013-2018)
8.1.3 Brazil Biosimilar Sales and Growth Rate (2013-2018)
8.1.4 Argentina Biosimilar Sales and Growth Rate (2013-2018)
8.1.5 Colombia Biosimilar Sales and Growth Rate (2013-2018)
8.2 South America Biosimilar Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Biosimilar Sales by Manufacturers (2016-2017)
8.2.2 South America Biosimilar Revenue by Manufacturers (2016-2017)
8.3 South America Biosimilar Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Biosimilar Sales and Sales Share by Type (2013-2018)
8.3.2 South America Biosimilar Revenue and Revenue Share by Type (2013-2018)
8.4 South America Biosimilar Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Biosimilar Sales and Sales Share by Application (2013-2018)
8.4.2 South America Biosimilar Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Biosimilar by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Biosimilar Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Biosimilar Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Biosimilar Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Biosimilar Sales and Growth Rate (2013-2018)
9.1.4 UAE Biosimilar Sales and Growth Rate (2013-2018)
9.1.5 Egypt Biosimilar Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Biosimilar Sales and Growth Rate (2013-2018)
9.1.7 South Africa Biosimilar Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Biosimilar Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Biosimilar Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Biosimilar Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Biosimilar Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Biosimilar Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Biosimilar Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Biosimilar Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Biosimilar Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Biosimilar Revenue and Revenue Share by Application (2013-2018)
10 Global Biosimilar Market Segment by Type
10.1 Global Biosimilar Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Biosimilar Sales and Market Share by Type (2013-2018)
10.1.2 Global Biosimilar Revenue and Market Share by Type (2013-2018)
10.2 Human Growth Hormones Sales Growth and Price
10.2.1 Global Human Growth Hormones Sales Growth (2013-2018)
10.2.2 Global Human Growth Hormones Price (2013-2018)
10.3 Monoclonal Antibodies Sales Growth and Price
10.3.1 Global Monoclonal Antibodies Sales Growth (2013-2018)
10.3.2 Global Monoclonal Antibodies Price (2013-2018)
10.4 Insulin Sales Growth and Price
10.4.1 Global Insulin Sales Growth (2013-2018)
10.4.2 Global Insulin Price (2013-2018)
10.5 Peptides Sales Growth and Price
10.5.1 Global Peptides Sales Growth (2013-2018)
10.5.2 Global Peptides Price (2013-2018)
10.6 Erythropoietin Sales Growth and Price
10.6.1 Global Erythropoietin Sales Growth (2013-2018)
10.6.2 Global Erythropoietin Price (2013-2018)
10.7 Others Sales Growth and Price
10.7.1 Global Others Sales Growth (2013-2018)
10.7.2 Global Others Price (2013-2018)
11 Global Biosimilar Market Segment by Application
11.1 Global Biosimilar Sales Market Share by Application (2013-2018)
11.2 Oncology Sales Growth (2013-2018)
11.3 Chronic and Autoimmune Diseases Sales Growth (2013-2018)
11.4 Growth Hormone Deficiency Sales Growth (2013-2018)
11.5 Infectious Diseases Sales Growth (2013-2018)
11.6 Others Sales Growth (2013-2018)
12 Biosimilar Market Forecast (2018-2023)
12.1 Global Biosimilar Sales, Revenue and Growth Rate (2018-2023)
12.2 Biosimilar Market Forecast by Regions (2018-2023)
12.2.1 North America Biosimilar Market Forecast (2018-2023)
12.2.2 Europe Biosimilar Market Forecast (2018-2023)
12.2.3 Asia-Pacific Biosimilar Market Forecast (2018-2023)
12.2.4 South America Biosimilar Market Forecast (2018-2023)
12.2.5 Middle East and Africa Biosimilar Market Forecast (2018-2023)
12.3 Biosimilar Market Forecast by Type (2018-2023)
12.3.1 Global Biosimilar Sales Forecast by Type (2018-2023)
12.3.2 Global Biosimilar Market Share Forecast by Type (2018-2023)
12.4 Biosimilar Market Forecast by Application (2018-2023)
12.4.1 Global Biosimilar Sales Forecast by Application (2018-2023)
12.4.2 Global Biosimilar Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Biosimilar Picture
Table Product Specifications of Biosimilar
Figure Global Biosimilar CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Biosimilar CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Biosimilar by Types in 2017
Figure Human Growth Hormones Picture
Table Major Manufacturers of Human Growth Hormones
Figure Monoclonal Antibodies Picture
Table Major Manufacturers of Monoclonal Antibodies
Figure Insulin Picture
Table Major Manufacturers of Insulin
Figure Peptides Picture
Table Major Manufacturers of Peptides
Figure Erythropoietin Picture
Table Major Manufacturers of Erythropoietin
Figure Others Picture
Table Major Manufacturers of Others
Figure Biosimilar Sales Market Share by Applications in 2017
Figure Oncology Picture
Figure Chronic and Autoimmune Diseases Picture
Figure Growth Hormone Deficiency Picture
Figure Infectious Diseases Picture
Figure Others Picture
Figure United States Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure France Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure UK Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure China Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure India Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Table Allergan plc Headquarter, Established, Main Business and Finance Overview (2017)
Table Allergan plc Biosimilar Production Bases, Sales Regions and Major Competitors
Table Allergan plc Biosimilar Product
Table Allergan plc Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Allergan plc Biosimilar Sales Market Share in 2017
Figure Global Allergan plc Biosimilar Revenue Market Share in 2017
Table BIOCAD Headquarter, Established, Main Business and Finance Overview (2017)
Table BIOCAD Biosimilar Production Bases, Sales Regions and Major Competitors
Table BIOCAD Biosimilar Product
Table BIOCAD Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global BIOCAD Biosimilar Sales Market Share in 2017
Figure Global BIOCAD Biosimilar Revenue Market Share in 2017
Table Biocon Headquarter, Established, Main Business and Finance Overview (2017)
Table Biocon Biosimilar Production Bases, Sales Regions and Major Competitors
Table Biocon Biosimilar Product
Table Biocon Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Biocon Biosimilar Sales Market Share in 2017
Figure Global Biocon Biosimilar Revenue Market Share in 2017
Table BioXpress Therapeutics SA Headquarter, Established, Main Business and Finance Overview (2017)
Table BioXpress Therapeutics SA Biosimilar Production Bases, Sales Regions and Major Competitors
Table BioXpress Therapeutics SA Biosimilar Product
Table BioXpress Therapeutics SA Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global BioXpress Therapeutics SA Biosimilar Sales Market Share in 2017
Figure Global BioXpress Therapeutics SA Biosimilar Revenue Market Share in 2017
Table Boehringer Ingelheim GmbH Headquarter, Established, Main Business and Finance Overview (2017)
Table Boehringer Ingelheim GmbH Biosimilar Production Bases, Sales Regions and Major Competitors
Table Boehringer Ingelheim GmbH Biosimilar Product
Table Boehringer Ingelheim GmbH Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Boehringer Ingelheim GmbH Biosimilar Sales Market Share in 2017
Figure Global Boehringer Ingelheim GmbH Biosimilar Revenue Market Share in 2017
Table Celltrion Inc. Headquarter, Established, Main Business and Finance Overview (2017)
Table Celltrion Inc. Biosimilar Production Bases, Sales Regions and Major Competitors
Table Celltrion Inc. Biosimilar Product
Table Celltrion Inc. Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Celltrion Inc. Biosimilar Sales Market Share in 2017
Figure Global Celltrion Inc. Biosimilar Revenue Market Share in 2017
Table Coherus BioSciences, Inc Headquarter, Established, Main Business and Finance Overview (2017)
Table Coherus BioSciences, Inc Biosimilar Production Bases, Sales Regions and Major Competitors
Table Coherus BioSciences, Inc Biosimilar Product
Table Coherus BioSciences, Inc Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Coherus BioSciences, Inc Biosimilar Sales Market Share in 2017
Figure Global Coherus BioSciences, Inc Biosimilar Revenue Market Share in 2017
Table Dr. Reddy's Laboratories Ltd. Headquarter, Established, Main Business and Finance Overview (2017)
Table Dr. Reddy's Laboratories Ltd. Biosimilar Production Bases, Sales Regions and Major Competitors
Table Dr. Reddy's Laboratories Ltd. Biosimilar Product
Table Dr. Reddy's Laboratories Ltd. Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Dr. Reddy's Laboratories Ltd. Biosimilar Sales Market Share in 2017
Figure Global Dr. Reddy's Laboratories Ltd. Biosimilar Revenue Market Share in 2017
Table Genor BioPharma Co. Ltd Headquarter, Established, Main Business and Finance Overview (2017)
Table Genor BioPharma Co. Ltd Biosimilar Production Bases, Sales Regions and Major Competitors
Table Genor BioPharma Co. Ltd Biosimilar Product
Table Genor BioPharma Co. Ltd Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Genor BioPharma Co. Ltd Biosimilar Sales Market Share in 2017
Figure Global Genor BioPharma Co. Ltd Biosimilar Revenue Market Share in 2017
Table Intas Pharmaceuticals Limited Headquarter, Established, Main Business and Finance Overview (2017)
Table Intas Pharmaceuticals Limited Biosimilar Production Bases, Sales Regions and Major Competitors
Table Intas Pharmaceuticals Limited Biosimilar Product
Table Intas Pharmaceuticals Limited Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Intas Pharmaceuticals Limited Biosimilar Sales Market Share in 2017
Figure Global Intas Pharmaceuticals Limited Biosimilar Revenue Market Share in 2017
Table Novartis AG
Table Novartis AG Biosimilar
Table Pfizer, Inc.
Table Pfizer, Inc. Biosimilar
Table Reliance Life Sciences
Table Reliance Life Sciences Biosimilar
Table Global Biosimilar Sales by Manufacturer (2016-2017)
Figure Global Biosimilar Sales Market Share by Manufacturer in 2016
Figure Global Biosimilar Sales Market Share by Manufacturer in 2017
Table Global Biosimilar Revenue by Manufacturer (2016-2017)
Figure Global Biosimilar Revenue Market Share by Manufacturer in 2016
Figure Global Biosimilar Revenue Market Share by Manufacturer in 2017
Table Global Biosimilar Price by Manufacturer (2016-2017)
Figure Top 3 Biosimilar Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Biosimilar Manufacturer (Revenue) Market Share in 2017
Figure Global Biosimilar Sales and Growth Rate (2013-2018)
Figure Global Biosimilar Revenue and Growth Rate (2013-2018)
Table Global Biosimilar Sales by Regions (2013-2018)
Table Global Biosimilar Sales Market Share by Regions (2013-2018)
Table Global Biosimilar Revenue by Regions (2013-2018)
Figure Global Biosimilar Revenue Market Share by Regions in 2013
Figure Global Biosimilar Revenue Market Share by Regions in 2017
Figure North America Biosimilar Sales and Growth Rate (2013-2018)
Figure North America Biosimilar Revenue and Growth Rate (2013-2018)
Figure Europe Biosimilar Sales and Growth Rate (2013-2018)
Figure Europe Biosimilar Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Biosimilar Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Biosimilar Revenue and Growth Rate (2013-2018)
Figure South America Biosimilar Sales and Growth Rate (2013-2018)
Figure South America Biosimilar Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Biosimilar Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Biosimilar Revenue and Growth Rate (2013-2018)
Figure North America Biosimilar Revenue and Growth Rate (2013-2018)
Table North America Biosimilar Sales by Countries (2013-2018)
Table North America Biosimilar Sales Market Share by Countries (2013-2018)
Figure North America Biosimilar Sales Market Share by Countries in 2013
Figure North America Biosimilar Sales Market Share by Countries in 2017
Table North America Biosimilar Revenue by Countries (2013-2018)
Table North America Biosimilar Revenue Market Share by Countries (2013-2018)
Figure North America Biosimilar Revenue Market Share by Countries in 2013
Figure North America Biosimilar Revenue Market Share by Countries in 2017
Figure United States Biosimilar Sales and Growth Rate (2013-2018)
Figure Canada Biosimilar Sales and Growth Rate (2013-2018)
Figure Mexico Biosimilar Sales and Growth Rate (2013-2018)
Table North America Biosimilar Sales by Manufacturer (2016-2017)
Figure North America Biosimilar Sales Market Share by Manufacturer in 2016
Figure North America Biosimilar Sales Market Share by Manufacturer in 2017
Table North America Biosimilar Revenue by Manufacturer (2016-2017)
Figure North America Biosimilar Revenue Market Share by Manufacturer in 2016
Figure North America Biosimilar Revenue Market Share by Manufacturer in 2017
Table North America Biosimilar Sales by Type (2013-2018)
Table North America Biosimilar Sales Share by Type (2013-2018)
Table North America Biosimilar Revenue by Type (2013-2018)
Table North America Biosimilar Revenue Share by Type (2013-2018)
Table North America Biosimilar Sales by Application (2013-2018)
Table North America Biosimilar Sales Share by Application (2013-2018)
Table North America Biosimilar Revenue by Application (2013-2018)
Table North America Biosimilar Revenue Share by Application (2013-2018)
Figure Europe Biosimilar Revenue and Growth Rate (2013-2018)
Table Europe Biosimilar Sales by Countries (2013-2018)
Table Europe Biosimilar Sales Market Share by Countries (2013-2018)
Table Europe Biosimilar Revenue by Countries (2013-2018)
Figure Europe Biosimilar Revenue Market Share by Countries in 2016
Figure Europe Biosimilar Revenue Market Share by Countries in 2017
Figure Germany Biosimilar Sales and Growth Rate (2013-2018)
Figure UK Biosimilar Sales and Growth Rate (2013-2018)
Figure France Biosimilar Sales and Growth Rate (2013-2018)
Figure Russia Biosimilar Sales and Growth Rate (2013-2018)
Figure Italy Biosimilar Sales and Growth Rate (2013-2018)
Table Europe Biosimilar Sales by Manufacturer (2016-2017)
Figure Europe Biosimilar Sales Market Share by Manufacturer in 2016
Figure Europe Biosimilar Sales Market Share by Manufacturer in 2017
Table Europe Biosimilar Revenue by Manufacturer (2016-2017)
Figure Europe Biosimilar Revenue Market Share by Manufacturer in 2016
Figure Europe Biosimilar Revenue Market Share
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs